{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:41:45Z","timestamp":1778604105951,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Three Lake Partners, LLC"},{"DOI":"10.13039\/100013415","name":"Purdue University Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Retrieval of circulating tumor cells (CTC) has proven valuable for assessing a patient's cancer burden, evaluating response to therapy, and analyzing which drug might treat a cancer best. Although most isolation methods retrieve CTCs based on size, shape, or capture by tumor-specific antibodies, we explore here the use of small molecule tumor-specific ligands linked to magnetic beads for CTC capture. We have designed folic acid-biotin conjugates with different linkers for the capture of folate receptor (FR)\u2009+\u2009tumor cells spiked into whole blood, and application of the same technology to isolate FR\u2009+\u2009CTCs from the peripheral blood of both tumor-bearing mice and non-small cell lung patients. We demonstrate that folic acid linked via a rigid linker to a flexible PEG spacer that is in turn tethered to a magnetic bead enables optimal CTC retrieval, reaching nearly 100% capture when 100 cancer cells are spiked into 1\u00a0mL of aqueous buffer and\u2009~\u200990% capture when the same quantity of cells is diluted into whole blood. In a live animal model, the same methodology is shown to efficiently retrieve CTCs from tumor-bearing mice, yielding cancer cell counts that are proportional to total tumor burden. More importantly, the same method is shown to collect\u2009~\u200929 CTCs\/8\u00a0mL peripheral blood from patients with non-small cell lung cancer. Since the ligand-presentation strategy optimized here should also prove useful in targeting other nanoparticles to other cells, the methods described below should have general applicability in the design of nanoparticles for cell-specific targeting.<\/jats:p>","DOI":"10.1038\/s41598-022-12118-3","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T16:03:44Z","timestamp":1653062624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands"],"prefix":"10.1038","volume":"12","author":[{"given":"Yingwen","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Napoleon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madduri","family":"Srinivasarao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagri A.","family":"Savran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"12118_CR1","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559\u20131564. https:\/\/doi.org\/10.1126\/science.1203543 (2011).","journal-title":"Science"},{"key":"12118_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.17294\/2330-0698.1017","volume":"1","author":"SF Moussavi-Harami","year":"2014","unstructured":"Moussavi-Harami, S. F., Wisinski, K. B. & Beebe, D. J. Circulating tumor cells in metastatic breast cancer: A prognostic and predictive marker. J. Patient-Centered Res. Rev. 1, 85\u201392. https:\/\/doi.org\/10.17294\/2330-0698.1017 (2014).","journal-title":"J. Patient-Centered Res. Rev."},{"key":"12118_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/annonc\/mdm583","volume":"19","author":"J Sastre","year":"2008","unstructured":"Sastre, J. et al. Circulating tumor cells in colorectal cancer: Correlation with clinical and pathological variables. Ann. Oncol. 19, 935\u2013938 (2008).","journal-title":"Ann. Oncol."},{"key":"12118_CR4","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","volume":"14","author":"JS De Bono","year":"2008","unstructured":"De Bono, J. S. et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14, 6302\u20136309 (2008).","journal-title":"Clin. Cancer Res."},{"key":"12118_CR5","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen, S. J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 3213\u20133221 (2008).","journal-title":"J. Clin. Oncol."},{"key":"12118_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrclinonc.2013.253","volume":"11","author":"MG Krebs","year":"2014","unstructured":"Krebs, M. G. et al. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat. Rev. Clin. Oncol. 11, 129\u2013144. https:\/\/doi.org\/10.1038\/nrclinonc.2013.253 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"12118_CR7","doi-asserted-by":"publisher","first-page":"26107","DOI":"10.18632\/oncotarget.8431","volume":"7","author":"F De Luca","year":"2016","unstructured":"De Luca, F. et al. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer. Oncotarget 7, 26107\u201326119. https:\/\/doi.org\/10.18632\/oncotarget.8431 (2016).","journal-title":"Oncotarget"},{"key":"12118_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.28092\/j.issn.2095-3941.2016.0007","volume":"13","author":"VA Forte","year":"2016","unstructured":"Forte, V. A. et al. The potential for liquid biopsies in the precision medical treatment of breast cancer. Cancer Biol. Med. 13, 19\u201340. https:\/\/doi.org\/10.28092\/j.issn.2095-3941.2016.0007 (2016).","journal-title":"Cancer Biol. Med."},{"key":"12118_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2016.07.021","volume":"100","author":"N Guibert","year":"2016","unstructured":"Guibert, N. et al. Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma. Lung Cancer 100, 1\u20134. https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.021 (2016).","journal-title":"Lung Cancer"},{"key":"12118_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2159-8290.cd-15-1483","volume":"6","author":"C Alix-Panabi\u00e8res","year":"2016","unstructured":"Alix-Panabi\u00e8res, C. & Pantel, K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 6, 479\u2013491. https:\/\/doi.org\/10.1158\/2159-8290.cd-15-1483 (2016).","journal-title":"Cancer Discov."},{"key":"12118_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/onc.2015.192","volume":"35","author":"K Pantel","year":"2016","unstructured":"Pantel, K. & Speicher, M. R. The biology of circulating tumor cells. Oncogene 35, 1216\u20131224. https:\/\/doi.org\/10.1038\/onc.2015.192 (2016).","journal-title":"Oncogene"},{"key":"12118_CR12","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1158\/1078-0432.CCR-12-1585","volume":"18","author":"FA Coumans","year":"2012","unstructured":"Coumans, F. A., Ligthart, S. T., Uhr, J. W. & Terstappen, L. W. Challenges in the enumeration and phenotyping of CTC. Clin. Cancer Res. 18, 5711\u20135718 (2012).","journal-title":"Clin. Cancer Res."},{"key":"12118_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel, K., Brakenhoff, R. H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329. https:\/\/doi.org\/10.1038\/nrc2375 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"12118_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2407-12-178","volume":"12","author":"TM Gorges","year":"2012","unstructured":"Gorges, T. M. et al. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12, 178\u2013178. https:\/\/doi.org\/10.1186\/1471-2407-12-178 (2012).","journal-title":"BMC Cancer"},{"key":"12118_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jama.2010.292","volume":"303","author":"M Cristofanilli","year":"2010","unstructured":"Cristofanilli, M. & Braun, S. Circulating tumor cells revisited. JAMA 303, 1092\u20131093 (2010).","journal-title":"JAMA"},{"key":"12118_CR16","first-page":"2598","volume":"9","author":"H Thurm","year":"2003","unstructured":"Thurm, H. et al. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. Clin. Cancer Res. 9, 2598\u20132604 (2003).","journal-title":"Clin. Cancer Res."},{"key":"12118_CR17","doi-asserted-by":"crossref","unstructured":"Lampignano, R., Schneck, H., Neumann, M., Fehm, T. & Neubauer, H. in Isolation and Molecular Characterization of Circulating Tumor Cells (eds Mark Jesus M. Magbanua & John W. Park) 181\u2013203 (Springer, 2017).","DOI":"10.1007\/978-3-319-55947-6_10"},{"key":"12118_CR18","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1080\/14737159.2016.1255144","volume":"16","author":"JF Swennenhuis","year":"2016","unstructured":"Swennenhuis, J. F., van Dalum, G., Zeune, L. L. & Terstappen, L. W. M. M. Improving the cell search\u00ae system. Expert Rev. Mol. Diagn. 16, 1291\u20131305 (2016).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"12118_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1373\/clinchem.2015.249706","volume":"62","author":"MT Gabriel","year":"2016","unstructured":"Gabriel, M. T., Calleja, L. R., Chalopin, A., Ory, B. & Heymann, D. Circulating tumor cells: A review of non\u2013EpCAM-based approaches for cell enrichment and isolation. Clin. Chem. 62, 571\u2013581. https:\/\/doi.org\/10.1373\/clinchem.2015.249706 (2016).","journal-title":"Clin. Chem."},{"key":"12118_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.01.002","volume":"125","author":"SJ Hao","year":"2018","unstructured":"Hao, S. J., Wan, Y., Xia, Y. Q., Zou, X. & Zheng, S. Y. Size-based separation methods of circulating tumor cells. Adv Drug Deliv Rev 125, 3\u201320. https:\/\/doi.org\/10.1016\/j.addr.2018.01.002 (2018).","journal-title":"Adv Drug Deliv Rev"},{"key":"12118_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13045-019-0735-4","volume":"12","author":"P Bank\u00f3","year":"2019","unstructured":"Bank\u00f3, P. et al. Technologies for circulating tumor cell separation from whole blood. J. Hematol. Oncol. 12, 48. https:\/\/doi.org\/10.1186\/s13045-019-0735-4 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"12118_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/clo-2008-0432","volume":"30","author":"S Lankiewicz","year":"2008","unstructured":"Lankiewicz, S. et al. Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell. Oncol. 30, 463\u2013471. https:\/\/doi.org\/10.3233\/clo-2008-0432 (2008).","journal-title":"Cell. Oncol."},{"key":"12118_CR23","first-page":"1823","volume":"27","author":"V Zieglschmid","year":"2007","unstructured":"Zieglschmid, V. et al. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer. Anticancer Res. 27, 1823\u20131832 (2007).","journal-title":"Anticancer Res."},{"key":"12118_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2217\/14622416.10.1.51","volume":"10","author":"RE Payne","year":"2008","unstructured":"Payne, R. E. et al. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. Pharmacogenomics 10, 51\u201357. https:\/\/doi.org\/10.2217\/14622416.10.1.51 (2008).","journal-title":"Pharmacogenomics"},{"key":"12118_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2407-9-424","volume":"9","author":"SC Winter","year":"2009","unstructured":"Winter, S. C. et al. Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma. BMC Cancer 9, 424\u2013424. https:\/\/doi.org\/10.1186\/1471-2407-9-424 (2009).","journal-title":"BMC Cancer"},{"key":"12118_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-009-0461-7","volume":"118","author":"M Pestrin","year":"2009","unstructured":"Pestrin, M. et al. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res. Treat. 118, 523. https:\/\/doi.org\/10.1007\/s10549-009-0461-7 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"12118_CR27","doi-asserted-by":"publisher","first-page":"e15624","DOI":"10.1371\/journal.pone.0015624","volume":"6","author":"M Ignatiadis","year":"2011","unstructured":"Ignatiadis, M. et al. HER2-positive circulating tumor cells in breast cancer. PLoS ONE 6, e15624. https:\/\/doi.org\/10.1371\/journal.pone.0015624 (2011).","journal-title":"PLoS ONE"},{"key":"12118_CR28","first-page":"1883","volume":"23","author":"A Stathopoulou","year":"2003","unstructured":"Stathopoulou, A. et al. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: Comparison of CK-19, CEA and maspin as detection markers. Anticancer Res. 23, 1883\u20131890 (2003).","journal-title":"Anticancer Res."},{"key":"12118_CR29","first-page":"1125","volume":"40","author":"W Kemmner","year":"2011","unstructured":"Kemmner, W. Currently used markers for CTC isolation-advantages, limitations and impact on cancer prognosis. J. Clin. Exp. Pathol. 40, 1125 (2011).","journal-title":"J. Clin. Exp. Pathol."},{"key":"12118_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","volume":"21","author":"B Aktas","year":"2011","unstructured":"Aktas, B., Kasimir-Bauer, S., Heubner, M., Kimmig, R. & Wimberger, P. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy. Int. J. Gynecol. Cancer 21, 822\u2013830. https:\/\/doi.org\/10.1097\/IGC.0b013e318216cb91 (2011).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"12118_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5732\/cjc.010.10239","volume":"30","author":"J-P Cheng","year":"2011","unstructured":"Cheng, J.-P. et al. MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer. Chin. J. Cancer 30, 54\u201361. https:\/\/doi.org\/10.5732\/cjc.010.10239 (2011).","journal-title":"Chin. J. Cancer"},{"key":"12118_CR32","doi-asserted-by":"publisher","first-page":"100075","DOI":"10.1016\/j.medidd.2020.100075","volume":"9","author":"FD Makurvet","year":"2021","unstructured":"Makurvet, F. D. Biologics vs. small molecules: Drug costs and patient access. Med. Drug Discov. 9, 100075. https:\/\/doi.org\/10.1016\/j.medidd.2020.100075 (2021).","journal-title":"Med. Drug Discov."},{"key":"12118_CR33","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","volume":"117","author":"M Srinivasarao","year":"2017","unstructured":"Srinivasarao, M. & Low, P. S. Ligand-targeted drug delivery. Chem. Rev. 117, 12133\u201312164 (2017).","journal-title":"Chem. Rev."},{"key":"12118_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/ar7000815","volume":"41","author":"PS Low","year":"2008","unstructured":"Low, P. S., Henne, W. A. & Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120\u2013129. https:\/\/doi.org\/10.1021\/ar7000815 (2008).","journal-title":"Acc. Chem. Res."},{"key":"12118_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","volume":"338","author":"N Parker","year":"2005","unstructured":"Parker, N. et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338, 284\u2013293 (2005).","journal-title":"Anal. Biochem."},{"key":"12118_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1021\/bc400441s","volume":"25","author":"CP Leamon","year":"2014","unstructured":"Leamon, C. P. et al. Folate-vinca alkaloid conjugates for cancer therapy: A structure-activity relationship. Bioconjug. Chem. 25, 560\u2013568. https:\/\/doi.org\/10.1021\/bc400441s (2014).","journal-title":"Bioconjug. Chem."},{"key":"12118_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v15.i6.20","volume":"15","author":"JA Reddy","year":"1998","unstructured":"Reddy, J. A. & Low, P. S. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 15, 223 (1998).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"12118_CR38","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jps.20457","volume":"94","author":"AR Hilgenbrink","year":"2005","unstructured":"Hilgenbrink, A. R. & Low, P. S. Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J. Pharm. Sci. 94, 2135\u20132146 (2005).","journal-title":"J. Pharm. Sci."},{"key":"12118_CR39","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P","volume":"89","author":"B Stella","year":"2000","unstructured":"Stella, B. et al. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89, 1452\u20131464 (2000).","journal-title":"J. Pharm. Sci."},{"key":"12118_CR40","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1073\/pnas.0703875104","volume":"104","author":"W He","year":"2007","unstructured":"He, W., Wang, H., Hartmann, L. C., Cheng, J.-X. & Low, P. S. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc. Natl. Acad. Sci. 104, 11760\u201311765 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"12118_CR41","doi-asserted-by":"publisher","first-page":"14055","DOI":"10.1021\/acsami.8b02583","volume":"10","author":"L Nie","year":"2018","unstructured":"Nie, L. et al. Folic acid targeting for efficient isolation and detection of ovarian cancer CTCs from human whole blood based on two-step binding strategy. ACS Appl. Mater. Interfaces. 10, 14055\u201314062. https:\/\/doi.org\/10.1021\/acsami.8b02583 (2018).","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"12118_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/jto.0000000000000606","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Folate receptor-positive circulating tumor cell detected by LT-PCR-based method as a diagnostic biomarker for non-small-cell lung cancer. J. Thorac. Oncol. 10, 1163\u20131171. https:\/\/doi.org\/10.1097\/jto.0000000000000606 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"12118_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/bmi.s35075","volume":"11","author":"DJ O\u2019Shannessy","year":"2016","unstructured":"O\u2019Shannessy, D. J., Davis, D. W., Anderes, K. & Somers, E. B. Isolation of circulating tumor cells from multiple epithelial cancers with ApoStream(\u00ae) for detecting (or Monitoring) the expression of folate receptor alpha. Biomarker Insights 11, 7\u201318. https:\/\/doi.org\/10.4137\/bmi.s35075 (2016).","journal-title":"Biomarker Insights"},{"key":"12118_CR44","first-page":"813","volume":"19","author":"H Lian","year":"2016","unstructured":"Lian, H., Ding, Z., Yuan, D., Ma, J. & Qin, J. Diagnostic value of folate receptor-positive circulating tumor cell in lung cancer: A pilot study. Chin. J. Lung Cancer 19, 813\u2013820 (2016).","journal-title":"Chin. J. Lung Cancer"},{"key":"12118_CR45","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.21037\/jtd.2016.05.38","volume":"8","author":"FZ Marino","year":"2016","unstructured":"Marino, F. Z., Ronchi, A., Accardo, M. & Franco, R. Detection of folate receptor\u2013positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients. J. Thorac. Dis. 8, 1437 (2016).","journal-title":"J. Thorac. Dis."},{"key":"12118_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1593\/tlo.13535","volume":"6","author":"Y Yu","year":"2013","unstructured":"Yu, Y. et al. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer. Transl. Oncol. 6, 697\u2013702 (2013).","journal-title":"Transl. Oncol."},{"key":"12118_CR47","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/JTO.0000000000000606","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Folate receptor-positive circulating tumor cell detected by LT-PCR\u2013based method as a diagnostic biomarker for non\u2013small-cell lung cancer. J. Thorac. Oncol. 10, 1163\u20131171. https:\/\/doi.org\/10.1097\/JTO.0000000000000606 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"12118_CR48","doi-asserted-by":"publisher","first-page":"e80458","DOI":"10.1371\/journal.pone.0080458","volume":"8","author":"J Lou","year":"2013","unstructured":"Lou, J. et al. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR. PLoS ONE 8, e80458 (2013).","journal-title":"PLoS ONE"},{"key":"12118_CR49","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.2217\/nnm.15.32","volume":"10","author":"S Bhana","year":"2015","unstructured":"Bhana, S., Wang, Y. & Huang, X. Nanotechnology for enrichment and detection of circulating tumor cells. Nanomedicine 10, 1973\u20131990 (2015).","journal-title":"Nanomedicine"},{"key":"12118_CR50","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1039\/C6CS00803H","volume":"46","author":"Z Shen","year":"2017","unstructured":"Shen, Z., Wu, A. & Chen, X. Current detection technologies for circulating tumor cells. Chem. Soc. Rev. 46, 2038\u20132056 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"12118_CR51","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1039\/d0tb01091j","volume":"8","author":"F Li","year":"2020","unstructured":"Li, F. et al. Nondestructive capture, release, and detection of circulating tumor cells with cystamine-mediated folic acid decorated magnetic nanospheres. J Mater Chem B 8, 9971\u20139979. https:\/\/doi.org\/10.1039\/d0tb01091j (2020).","journal-title":"J Mater Chem B"},{"key":"12118_CR52","doi-asserted-by":"publisher","first-page":"14055","DOI":"10.1021\/acsami.8b02583","volume":"10","author":"L Nie","year":"2018","unstructured":"Nie, L. et al. Folic acid targeting for efficient isolation and detection of ovarian cancer CTCs from human whole blood based on two-step binding strategy. ACS Appl. Mater. Interfaces 10, 14055\u201314062. https:\/\/doi.org\/10.1021\/acsami.8b02583 (2018).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"12118_CR53","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","volume":"10","author":"FM Veronese","year":"2005","unstructured":"Veronese, F. M. & Pasut, G. PEGylation, successful approach to drug delivery. Drug Discov. Today 10, 1451\u20131458. https:\/\/doi.org\/10.1016\/S1359-6446(05)03575-0 (2005).","journal-title":"Drug Discov. Today"},{"key":"12118_CR54","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1021\/nn402644g","volume":"7","author":"E Vlashi","year":"2013","unstructured":"Vlashi, E., Kelderhouse, L. E., Sturgis, J. E. & Low, P. S. Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. ACS Nano 7, 8573\u20138582. https:\/\/doi.org\/10.1021\/nn402644g (2013).","journal-title":"ACS Nano"},{"key":"12118_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pharmaceutics12060533","volume":"12","author":"H Lee","year":"2020","unstructured":"Lee, H. Molecular simulations of PEGylated biomolecules, liposomes, and nanoparticles for drug delivery applications. Pharmaceutics 12, 533 (2020).","journal-title":"Pharmaceutics"},{"key":"12118_CR56","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1016\/S0021-9258(17)41848-5","volume":"269","author":"RJ Lee","year":"1994","unstructured":"Lee, R. J. & Low, P. S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198\u20133204 (1994).","journal-title":"J. Biol. Chem."},{"key":"12118_CR57","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1073\/pnas.93.13.6676","volume":"93","author":"SC Li","year":"1996","unstructured":"Li, S. C., Goto, N. K., Williams, K. A. & Deber, C. M. Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. Proc. Natl. Acad. Sci. U.S.A. 93, 6676\u20136681 (1996).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"12118_CR58","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1006\/jmbi.1998.2217","volume":"284","author":"I Nilsson","year":"1998","unstructured":"Nilsson, I. et al. Proline-induced disruption of a transmembrane \u03b1-helix in its natural environment. J. Mol. Biol. 284, 1165\u20131175 (1998).","journal-title":"J. Mol. Biol."},{"key":"12118_CR59","first-page":"1421","volume":"24","author":"M Katoh","year":"2004","unstructured":"Katoh, M., Neumaier, M., Nezam, R., Izbicki, J. R. & Schumacher, U. Correlation of circulating tumor cells with tumor size and metastatic load in a spontaneous lung metastasis model. Anticancer Res. 24, 1421\u20131426 (2004).","journal-title":"Anticancer Res."},{"key":"12118_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cellimm.2015.11.009","volume":"300","author":"T Yin","year":"2016","unstructured":"Yin, T. et al. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells. Cell. Immunol. 300, 41\u201345 (2016).","journal-title":"Cell. Immunol."},{"key":"12118_CR61","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 119, 1420\u20131428 (2009).","journal-title":"J. Clin. Investig."},{"key":"12118_CR62","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1373\/clinchem.2015.248260","volume":"62","author":"M-C Chang","year":"2016","unstructured":"Chang, M.-C. et al. Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma. Clin. Chem. 62, 505\u2013513. https:\/\/doi.org\/10.1373\/clinchem.2015.248260 (2016).","journal-title":"Clin. Chem."},{"key":"12118_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12935-016-0373-7","volume":"17","author":"D Zhang","year":"2017","unstructured":"Zhang, D. et al. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy. Cancer Cell Int. 17, 6. https:\/\/doi.org\/10.1186\/s12935-016-0373-7 (2017).","journal-title":"Cancer Cell Int."},{"key":"12118_CR64","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1021\/acs.molpharmaceut.8b00139","volume":"15","author":"IS Marks","year":"2018","unstructured":"Marks, I. S. et al. Development of a small molecule tubulysin B conjugate for treatment of carbonic anhydrase IX receptor expressing cancers. Mol Pharm 15, 2289\u20132296. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00139 (2018).","journal-title":"Mol Pharm"},{"key":"12118_CR65","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1021\/acs.bioconjchem.8b00164","volume":"29","author":"J Roy","year":"2018","unstructured":"Roy, J., Kaake, M., Srinivasarao, M. & Low, P. S. Targeted tubulysin B hydrazide conjugate for the treatment of luteinizing hormone-releasing hormone receptor-positive cancers. Bioconjug. Chem. 29, 2208\u20132214. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00164 (2018).","journal-title":"Bioconjug. Chem."},{"key":"12118_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11307-019-01391-w","volume":"22","author":"AK Kanduluru","year":"2020","unstructured":"Kanduluru, A. K., Srinivasarao, M., Wayua, C. & Low, P. S. Evaluation of a neurokinin-1 receptor-targeted technetium-99m conjugate for neuroendocrine cancer imaging. Mol. Imag. Biol. 22, 377\u2013383 (2020).","journal-title":"Mol. Imag. Biol."},{"key":"12118_CR67","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1021\/mp900069d","volume":"6","author":"SA Kularatne","year":"2009","unstructured":"Kularatne, S. A., Wang, K., Santhapuram, H. K. & Low, P. S. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol. Pharm. 6, 780\u2013789. https:\/\/doi.org\/10.1021\/mp900069d (2009).","journal-title":"Mol. Pharm."},{"key":"12118_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2967\/jnumed.114.144998","volume":"56","author":"C Wayua","year":"2015","unstructured":"Wayua, C. & Low, P. S. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers. J. Nucl. Med. 56, 113\u2013119. https:\/\/doi.org\/10.2967\/jnumed.114.144998 (2015).","journal-title":"J. Nucl. Med."},{"key":"12118_CR69","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1021\/acs.bioconjchem.8b00509","volume":"29","author":"SM Mahalingam","year":"2018","unstructured":"Mahalingam, S. M., Chu, H., Liu, X., Leamon, C. P. & Low, P. S. Carbonic anhydrase IX-targeted near-infrared dye for fluorescence imaging of hypoxic tumors. Bioconjug Chem. 29, 3320\u20133331. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00509 (2018).","journal-title":"Bioconjug Chem."},{"key":"12118_CR70","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","volume":"59","author":"D Sneddon","year":"2016","unstructured":"Sneddon, D. et al. Synthesis and in vivo biological evaluation of (68)Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography. J. Med. Chem. 59, 6431\u20136443. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00623 (2016).","journal-title":"J. Med. Chem."},{"key":"12118_CR71","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.bmcl.2014.02.002","volume":"24","author":"DE Olberg","year":"2014","unstructured":"Olberg, D. E. et al. Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression. Bioorg. Med. Chem. Lett. 24, 1846\u20131850. https:\/\/doi.org\/10.1016\/j.bmcl.2014.02.002 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"12118_CR72","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1021\/acs.bioconjchem.8b00063","volume":"29","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Synthesis and evaluation of a novel (64)Cu- and (67)Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts. Bioconjug Chem. 29, 1319\u20131326. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00063 (2018).","journal-title":"Bioconjug Chem."},{"key":"12118_CR73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2310\/7290.2010.00032","volume":"10","author":"M Brom","year":"2011","unstructured":"Brom, M. et al. Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2\/gastrin receptor-positive tumors. Mol. Imaging 10, 144\u2013152 (2011).","journal-title":"Mol. Imaging"},{"key":"12118_CR74","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1039\/c9sc04655k","volume":"11","author":"BA Vaughn","year":"2020","unstructured":"Vaughn, B. A. et al. Chelation with a twist: A bifunctional chelator to enable room temperature radiolabeling and targeted PET imaging with scandium-44. Chem. Sci. 11, 333\u2013342. https:\/\/doi.org\/10.1039\/c9sc04655k (2020).","journal-title":"Chem. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12118-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:26:28Z","timestamp":1669346788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12118"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12118-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8555"}}